Niagen Bioscience Inc (NASDAQ:NAGE) currently has a daily average trading volume of 1.14M but it saw 962038 shares traded in last market. With a market cap of 864.89M USD, the company’s current market price of $10.98 came rising about 3.58 while comparing to the previous closing price of $10.60. In past 52 weeks, the stock remained buoying in the range of price level as high as $11.06 and as low as $2.31.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Canaccord Genuity which initiated the stock as “Buy” in its note to investors issued on May 27, 2025, recommending a price target of $13 for it. B. Riley Securities issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $6 and $2.40.
Over the week, NAGE’s stock price is moving 2.04% up while it is 44.09% when we observe its performance for the past one month. Year-to-date it is 106.97% up and over the past year, the stock is showing an upside performance of 237.85%.
Currently, Niagen Bioscience Inc’s total number of outstanding shares is 78.43M with 34.44% of that held by the insiders while 32.75% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 24.35% and return on equity (ROE) at 33.47%. It has a price to earnings ratio (P/E ratio) of 63.58 while having a 47.34 of forward P/E ratio. Stock’s beta reads 2.08. Stock has a price to book (P/B) ratio of 15.56 while price to sale or P/S ratio amounts to 8.01. Its return on asset (ROA) is 20.83% on average.
